A new class of weight loss/obesity drugs called semaglutides, a diabetes drug that also has weight loss effects, could be responsible for transforming the economy in many sectors, analysts say. Ozempic is one of the major brand names, and works by mimicking a naturally occurring hormone. As those hormone levels rise, the molecules go to your brain, telling it you're full. It also slows digestion by increasing the time it takes for food to leave the body. This is similar to the effect of bariatric surgery.
https://www.businessinsider.com/semaglutide-wegovy-ozempic-weight-loss-healthcare-airlines-economy-productivity-2023-11
Insurance companies haven't been lining up to cover the drugs, which costs somewhere between $900 and $1200 per month. Medicare does not cover them at all.
Thoughts?